首页    期刊浏览 2024年10月06日 星期日
登录注册

文章基本信息

  • 标题:Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model
  • 本地全文:下载
  • 作者:Yuya Yoshida ; Norihisa Mikami ; Yuki Matsushima
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2015
  • 卷号:38
  • 期号:8
  • 页码:1120-1125
  • DOI:10.1248/bpb.b14-00873
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:We previously reported that combination treatment with fingolimod (FTY720) plus antigenic peptide of glucose-6-phosphate isomerase (residues 325–339) (GPI325–339) from the onset of symptoms significantly inhibited disease progression in a mouse model of GPI325–339-induced arthritis. In this study, we investigated the mechanism(s) involved. The model mice were treated from arthritis onset with FTY720 alone, GPI325–339 alone, or the combination of FTY720 plus GPI325–339. At the end of treatment, inguinal lymph nodes (LNs) were excised and examined histologically and in flow cytometry. Levels of apoptotic cells, programmed death-1-expressing CD4+forkhead box P3 nonregulatory T cells (non-Tregs), and cytotoxic T-lymphocyte antigen 4-expressing non-Tregs in inguinal LNs were markedly increased in the combination treatment group mice. Regulatory T cells (Tregs) were also increased. These results indicate that combination treatment with FTY720 plus GPI325–339 inhibits the progression of arthritis by inducing clonal deletion and anergy of pathogenic T cells and also by immune suppression via Tregs.
国家哲学社会科学文献中心版权所有